IP Strategy & Audits

The Nagoya Protocol and the UK – are you compliant? The Nagoya Protocol has been in force in the UK since October 2015 and obliges users of genetic resources and traditional knowledge associated with genetic resources to comply with due diligence requirements before its ‘utilisation’. There is also an obligation to make a due diligence… Read more »

UK government faces challenges over future exhaustion of IP rights regime Brexit created ‘one way door’ policy for parallel imports, say AA Thornton partners Ian Gill and Dan Byrne This article was first posted by The Global Legal Post  as event coverage for Ian and Dan’s presentation ‘Exhaustion of rights’ for the Anti-counterfeiting World Summit…. Read more »

Deadline approaching for the Government R&D Tax Credits Consultation – your input needed for potential changes to RDEC and SME R&D Relief Government R&D Tax Credits Consultation: The UK government intends to raise investment in research and development to 2.4% of UK GDP by 2027 and wants to ensure that one of the key incentives for… Read more »

Ian Gill reports on how miniscule trademark use may be enough to support a passing off claim and maintain a EU trademark registration. This article was written by Ian for the IPKat legal blog Don’t be fooled: decision O/050/21 is not just another unsuccessful appeal to the UK Appointed Person (approximately 85% of such appeals are unsuccessful). Underlying… Read more »

Copyright in AI 2021 – Sarah Neil shares an update on the progress in the UK’s review of artificial intelligence and intellectual property   As we have mentioned in previous articles how having a range of IP is an important part of a strong portfolio in the protection of your AI business. The ever accelerating… Read more »

Designs in AI 2021 – Sarah Neil shares an update on the progress in the UK’s review of artificial intelligence and intellectual property   As we have mentioned in previous articles how having a range of IP, including Designs, is an important part of a strong portfolio in the protection of your AI business. The… Read more »

Trade marks in AI 2021 – Sarah Neil shares an update on the progress in the UK’s review of artificial intelligence and intellectual property   As we have mentioned in previous articles trade marks in AI are an important part of a strong portfolio in the protection of your AI business. The ever accelerating landscape… Read more »

G1/19 decision – Patenting Computer Simulation in Europe The much anticipated G1/19 decision has arrived with the EPO Enlarged Board of Appeal confirming that the EPO’s established approach to the assessment of inventive step of computer-implemented inventions is the correct approach for computer-implemented simulation methods. On 10 March 2021, the Enlarged Board issued decision G1/19 and… Read more »

Trademark assignments and the transfer of the goodwill seem, well, oh-so dull, until they are not. Ian Gill reports on a recent cautionary tale from the UK. This is an expanded version of an article that was written by the author and  first published in IPKat in February 2021 Scott Hallsworth (‘SH’) is a renowned Australian chef… Read more »

Amgen v Sanofi and Regeneron: Broad antibody patents held invalid for lack of enablement in US Lack of enablement: A conclusion of lack of enablement means that the disclosure provided in the patent specification, at the time the application was filed, would not have taught one skilled in the art how to make and/or use the full… Read more »